mRNA Development and Manufacturing – CMC challenges and Solutions
Summary: Breaking New Ground: Turning mRNA into an Established Therapeutic Modality (Video 2 of 3 in the mRNA fireside chat series with Catalent’s experts). Once one of the riskiest new technologies in drug R&D, the pandemic made mRNA a household word, with BioNTech and Moderna driving quickly to global regulatory approvals for their blockbuster vaccines. mRNA has gained tremendous attention in recent years. In addition to COVID-19, among the RNA-based therapeutics, mRNA have the potential to treat a variety of diseases.